Elevated oxidized lipids, anti-lipid autoantibodies and oxidized lipid immune complexes in active SLE

Yujin Ye, Tianfu Wu, Ting Zhang, Jie Han, Deena Habazi, Ramesh Saxena, Chandra Mohan

Research output: Contribution to journalArticle

Abstract

Background: Here, we explore the serum levels of anti-oxidized lipid autoantibodies as well as immune complexes in patients with SLE and determine their correlation with disease. Methods: Serum levels of oxidized-LDL immune complexes, autoantibodies to dsDNA, ox-LDL, MDA-LDL, 9-HODE, 13-HODE and POVPC were detected by ELISA in 64 SLE patients and 9 healthy controls. Results: Active SLE patients exhibited increased serum levels of autoantibodies compared to healthy controls, including anti-MDA-LDL-IgG (p = .003), anti-ox-LDL-IgG (p = .004), anti-9-HODE-IgG (p = .001), anti-13-HODE-IgG (p = .0003), anti-POVPC-IgG (p = .001) and ox-LDL-IC (p = .003). Serum anti-ox-LDL-IgG was positively correlated with SLEDAI (r = 0.34; p = .01), and negatively with C3 (r = −0.40; p = .01). Anti-9-HODE-IgG and anti-POVPC-IgG were positively correlated with SLEDAI and negatively with C4. Conclusions: Active SLE patients exhibit significantly increased serum levels of IgG anti-oxidized-lipid autoantibodies. Coordinated elevation of oxidized lipids, autoantibodies to these lipids, and immune complexes of these lipid-antibody components could potentially serve as pathogenic drivers and serum markers of SLE disease activity.

Original languageEnglish (US)
Pages (from-to)43-48
Number of pages6
JournalClinical Immunology
Volume205
DOIs
StatePublished - Aug 1 2019

Fingerprint

Antigen-Antibody Complex
Autoantibodies
Lipids
Immunoglobulin G
Serum
oxidized low density lipoprotein
Biomarkers
Enzyme-Linked Immunosorbent Assay
Antibodies
anti-IgG
9-hydroxy-10,12-octadecadienoic acid

Keywords

  • Autoantibodies
  • Oxidized lipid
  • Systemic lupus erythematosus (SLE)

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Elevated oxidized lipids, anti-lipid autoantibodies and oxidized lipid immune complexes in active SLE. / Ye, Yujin; Wu, Tianfu; Zhang, Ting; Han, Jie; Habazi, Deena; Saxena, Ramesh; Mohan, Chandra.

In: Clinical Immunology, Vol. 205, 01.08.2019, p. 43-48.

Research output: Contribution to journalArticle

Ye, Yujin ; Wu, Tianfu ; Zhang, Ting ; Han, Jie ; Habazi, Deena ; Saxena, Ramesh ; Mohan, Chandra. / Elevated oxidized lipids, anti-lipid autoantibodies and oxidized lipid immune complexes in active SLE. In: Clinical Immunology. 2019 ; Vol. 205. pp. 43-48.
@article{eb513133129040a3bd0e69abed5ac307,
title = "Elevated oxidized lipids, anti-lipid autoantibodies and oxidized lipid immune complexes in active SLE",
abstract = "Background: Here, we explore the serum levels of anti-oxidized lipid autoantibodies as well as immune complexes in patients with SLE and determine their correlation with disease. Methods: Serum levels of oxidized-LDL immune complexes, autoantibodies to dsDNA, ox-LDL, MDA-LDL, 9-HODE, 13-HODE and POVPC were detected by ELISA in 64 SLE patients and 9 healthy controls. Results: Active SLE patients exhibited increased serum levels of autoantibodies compared to healthy controls, including anti-MDA-LDL-IgG (p = .003), anti-ox-LDL-IgG (p = .004), anti-9-HODE-IgG (p = .001), anti-13-HODE-IgG (p = .0003), anti-POVPC-IgG (p = .001) and ox-LDL-IC (p = .003). Serum anti-ox-LDL-IgG was positively correlated with SLEDAI (r = 0.34; p = .01), and negatively with C3 (r = −0.40; p = .01). Anti-9-HODE-IgG and anti-POVPC-IgG were positively correlated with SLEDAI and negatively with C4. Conclusions: Active SLE patients exhibit significantly increased serum levels of IgG anti-oxidized-lipid autoantibodies. Coordinated elevation of oxidized lipids, autoantibodies to these lipids, and immune complexes of these lipid-antibody components could potentially serve as pathogenic drivers and serum markers of SLE disease activity.",
keywords = "Autoantibodies, Oxidized lipid, Systemic lupus erythematosus (SLE)",
author = "Yujin Ye and Tianfu Wu and Ting Zhang and Jie Han and Deena Habazi and Ramesh Saxena and Chandra Mohan",
year = "2019",
month = "8",
day = "1",
doi = "10.1016/j.clim.2019.05.004",
language = "English (US)",
volume = "205",
pages = "43--48",
journal = "Clinical Immunology",
issn = "1521-6616",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Elevated oxidized lipids, anti-lipid autoantibodies and oxidized lipid immune complexes in active SLE

AU - Ye, Yujin

AU - Wu, Tianfu

AU - Zhang, Ting

AU - Han, Jie

AU - Habazi, Deena

AU - Saxena, Ramesh

AU - Mohan, Chandra

PY - 2019/8/1

Y1 - 2019/8/1

N2 - Background: Here, we explore the serum levels of anti-oxidized lipid autoantibodies as well as immune complexes in patients with SLE and determine their correlation with disease. Methods: Serum levels of oxidized-LDL immune complexes, autoantibodies to dsDNA, ox-LDL, MDA-LDL, 9-HODE, 13-HODE and POVPC were detected by ELISA in 64 SLE patients and 9 healthy controls. Results: Active SLE patients exhibited increased serum levels of autoantibodies compared to healthy controls, including anti-MDA-LDL-IgG (p = .003), anti-ox-LDL-IgG (p = .004), anti-9-HODE-IgG (p = .001), anti-13-HODE-IgG (p = .0003), anti-POVPC-IgG (p = .001) and ox-LDL-IC (p = .003). Serum anti-ox-LDL-IgG was positively correlated with SLEDAI (r = 0.34; p = .01), and negatively with C3 (r = −0.40; p = .01). Anti-9-HODE-IgG and anti-POVPC-IgG were positively correlated with SLEDAI and negatively with C4. Conclusions: Active SLE patients exhibit significantly increased serum levels of IgG anti-oxidized-lipid autoantibodies. Coordinated elevation of oxidized lipids, autoantibodies to these lipids, and immune complexes of these lipid-antibody components could potentially serve as pathogenic drivers and serum markers of SLE disease activity.

AB - Background: Here, we explore the serum levels of anti-oxidized lipid autoantibodies as well as immune complexes in patients with SLE and determine their correlation with disease. Methods: Serum levels of oxidized-LDL immune complexes, autoantibodies to dsDNA, ox-LDL, MDA-LDL, 9-HODE, 13-HODE and POVPC were detected by ELISA in 64 SLE patients and 9 healthy controls. Results: Active SLE patients exhibited increased serum levels of autoantibodies compared to healthy controls, including anti-MDA-LDL-IgG (p = .003), anti-ox-LDL-IgG (p = .004), anti-9-HODE-IgG (p = .001), anti-13-HODE-IgG (p = .0003), anti-POVPC-IgG (p = .001) and ox-LDL-IC (p = .003). Serum anti-ox-LDL-IgG was positively correlated with SLEDAI (r = 0.34; p = .01), and negatively with C3 (r = −0.40; p = .01). Anti-9-HODE-IgG and anti-POVPC-IgG were positively correlated with SLEDAI and negatively with C4. Conclusions: Active SLE patients exhibit significantly increased serum levels of IgG anti-oxidized-lipid autoantibodies. Coordinated elevation of oxidized lipids, autoantibodies to these lipids, and immune complexes of these lipid-antibody components could potentially serve as pathogenic drivers and serum markers of SLE disease activity.

KW - Autoantibodies

KW - Oxidized lipid

KW - Systemic lupus erythematosus (SLE)

UR - http://www.scopus.com/inward/record.url?scp=85065911697&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065911697&partnerID=8YFLogxK

U2 - 10.1016/j.clim.2019.05.004

DO - 10.1016/j.clim.2019.05.004

M3 - Article

C2 - 31075396

AN - SCOPUS:85065911697

VL - 205

SP - 43

EP - 48

JO - Clinical Immunology

JF - Clinical Immunology

SN - 1521-6616

ER -